Efficacy of repeat-dose rituximab maintenance therapy for minimal change disease in adults

被引：0
|
作者：
Shinya Taguchi
Takayasu Ohtake
Yasuhiro Mochida
Kunihiro Ishioka
Hidekazu Moriya
Sumi Hidaka
Shuzo Kobayashi
机构：
[1] Shonan Kamakura General Hospital,Kidney Disease and Transplant Center
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Minimal change disease; Nephrotic syndrome; Relapse; Rituximab; B-cell depletion; Steroid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1132 / 1139
页数：7
相关论文
共 50 条
  • [31] The Treatment of Minimal Change Disease in Adults
    Hogan, Jonathan
    Radhakrishnan, Jai
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (05): : 702 - 711
  • [32] Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease
    Leung, Wing Yin
    Wu, Henry H. L.
    Woywodt, Alexander
    Ponnusamy, Arvind
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [33] Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease
    Campochiaro, Corrado
    Della-Torre, Emanuel
    Lanzillotta, Marco
    Bozzolo, Enrica
    Baldissera, Elena
    Milani, Raffaella
    Arcidiacono, Paolo Giorgio
    Crippa, Stefano
    Falconi, Massimo
    Dagna, Lorenzo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 92 - 98
  • [34] Optimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance
    Roy, Rupali
    Gordon, Leo I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (05): : 563 - 571
  • [35] Clearing minimal residual disease with rituximab consolidation therapy
    Brugger, W
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 33 - 37
  • [36] RITUXIMAB IN TREATMENT OF MINIMAL CHANGE DISEASE AND PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ADULTS - SINGLE CENTER EXPERIENCE
    Zagorec, Nikola
    Horvatic, Ivica
    Kasumovic, Dino
    Toric, Luka
    Senjug, Petar
    Ljubanovic, Danica Galesic
    Galesic, Kresimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I162 - I162
  • [37] Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis
    Allinovi, Marco
    Trivioli, Giorgio
    Lugli, Gianmarco
    Villanti, Maurizio
    Gianassi, Iacopo
    Antognoli, Giulia
    Romagnani, Paola
    Vaglio, Augusto
    Caroti, Leonardo
    Cirami, Calogero Lino
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (04) : 789 - 791
  • [38] LONG TERM FOLLOW UP OF PATIENTS WHO RECEIVED REPEAT DOSE RITUXIMAB AS MAINTENANCE THERAPY FOR ANCA ASSOCIATED VASCULITIS (AAV)
    Alberici, Federico
    Smith, Rona
    Jones, Rachel
    Jayne, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 2 - 2
  • [39] Long term follow up of patients who received repeat dose rituximab as maintenance therapy for ANCA associated vasculitis (AAV)
    Smith, R.
    Alberici, F.
    Jones, R.
    Jayne, D.
    PRESSE MEDICALE, 2013, 42 (04): : 775 - 776
  • [40] Rituximab in Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis
    Kronbichler, Andreas
    Bruchfeld, Annette
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 277 - 282
12345